Trial intelligence / Profile preview

Dermagraft in adults with venous leg ulcers

2009-010062-33Phase 3Completed

Sponsor
Advanced BioHealing
Start
Apr 2009
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Phase 3, randomised, open-label trial of Foreskin fibroblast (neonatal) in stasis ulcer (2 arms), sponsored by Advanced BioHealing. Primary endpoint: Complete healing of ulcer by 16 weeks. Started Apr 2009; status: completed.

02

Drugs

Foreskin fibroblast (neonatal)
03

Conditions

stasis ulcer

Beyond the preview

Go deeper on 2009-010062-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010062-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call